Difference in Antibody Responses to Mycobacterium tuberculosis Antigens in Japanese Tuberculosis Patients Infected with the Beijing/Non-Beijing Genotype

Table 2

Non-Beijing genotype subgroups.

	Subtypes of non-Beijing MTB
Genotype	EAI2 Manila	LAM9	New type	T1	T2	T3-OSA
Number of MDR strains (%)	0	0	0	2 (40%)	0	0
Anti-LAM	1.34 (0.33–2.35)	1.01	0.84 (0.09–2.5)	1.37 (0.33–2.29)	0.310	1.89 (1.76–2.03)
Anti-TBGL	2.71 (2.11–3.30)	12.44	0.57 (0.07–11.9)	34.1 (0.12–62.6)	1.11	38.8 (4.9–72.6)
Anti-TBGL	7.28 (0.37–14.2)	0.45	0.54 (0.44–39.2)	0.83 (0.38–8.38)	2.13	4.7 (1.72–77.0)
Anti-	1.31 (1.01–1.61)	0.37	1.17 (0.72–3.16)	1.61 (0.94–2.32)	3.54	2.07
Anti-	0.15 (0.12–0.17)	0.15	0.15 (0.09–0.16)	0.21 (0.06–1.47)	3.35	3.61

(range), EAI 2 Manila Clade EAI2 from the Manila family strain; LAM9, Latin American-Mediterranean; T1, specific T1 genotype clone (SIT number 266); T2, T2 Mycobacterium tuberculosis genotype.